Trial Details
COMPLETEDBasic Information
| Clinical ID | c1744 |
|---|---|
| Identifier | NCT03077412 |
| Trial Title | Study to Evaluate the Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Fistulizing Crohn's Disease |
| Interventions | DRUG: Filgotinib|DRUG: Placebo to match filgotinib |
Participant Information
| Sponsor | Gilead Sciences |
|---|---|
| City | Miami |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2017-04-06 |
|---|---|
| Primary Completion Date | 2021-01-20 |
| Completion Date | 2021-02-17 |